Research progress in unilateral moyamoya disease

Unilateral moyamoya disease (U-MMD) is a chronic vascular disease characterized by progressive stenosis and occlusion of the terminal end of the internal carotid artery and its main branches, resulting in the appearance of moyamoya-like blood vessels at the base of the brain. The etiology of U-MMD i...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaokuan Hao, Cunxin Tan, Ziqi Liu, Yang Tie, Yanru Wang, Shihao He, Ran Duan, Rong Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Human Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnhum.2025.1503639/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832585017184747520
author Xiaokuan Hao
Cunxin Tan
Ziqi Liu
Yang Tie
Yanru Wang
Shihao He
Ran Duan
Rong Wang
Rong Wang
author_facet Xiaokuan Hao
Cunxin Tan
Ziqi Liu
Yang Tie
Yanru Wang
Shihao He
Ran Duan
Rong Wang
Rong Wang
author_sort Xiaokuan Hao
collection DOAJ
description Unilateral moyamoya disease (U-MMD) is a chronic vascular disease characterized by progressive stenosis and occlusion of the terminal end of the internal carotid artery and its main branches, resulting in the appearance of moyamoya-like blood vessels at the base of the brain. The etiology of U-MMD is unknown, it accounts for 9.7–17.8% of all moyamoya disease, and the family incidence is 5.5–13.3%. The clinical characteristics are similar to those of typical moyamoya disease, but there are some differences. U-MMD can progress to bilateral moyamoya disease with a median probability of 29.01% (ranging from 6.3 to 58.8%), and there are many risk factors that promote its development. Surgical treatment can effectively reduce the incidence of ischemic stroke and improve prognosis. However, the timing and indications for surgery require further investigation. This article reviews the latest research progress on the etiology, epidemiology, clinical and radiological characteristics, progression, treatment, and prognosis of U-MMD.
format Article
id doaj-art-ad70680a924d43d385e5cd0186fd263a
institution Kabale University
issn 1662-5161
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Human Neuroscience
spelling doaj-art-ad70680a924d43d385e5cd0186fd263a2025-01-27T06:40:20ZengFrontiers Media S.A.Frontiers in Human Neuroscience1662-51612025-01-011910.3389/fnhum.2025.15036391503639Research progress in unilateral moyamoya diseaseXiaokuan Hao0Cunxin Tan1Ziqi Liu2Yang Tie3Yanru Wang4Shihao He5Ran Duan6Rong Wang7Rong Wang8Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaDepartment of Neurosurgery, Peking University International Hospital, Beijing, ChinaDepartment of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaDepartment of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaDepartment of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaDepartment of Neurosurgery, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, ChinaDepartment of Neurosurgery, Peking University International Hospital, Beijing, ChinaDepartment of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaChina National Clinical Research Center for Neurological Diseases, Beijing, ChinaUnilateral moyamoya disease (U-MMD) is a chronic vascular disease characterized by progressive stenosis and occlusion of the terminal end of the internal carotid artery and its main branches, resulting in the appearance of moyamoya-like blood vessels at the base of the brain. The etiology of U-MMD is unknown, it accounts for 9.7–17.8% of all moyamoya disease, and the family incidence is 5.5–13.3%. The clinical characteristics are similar to those of typical moyamoya disease, but there are some differences. U-MMD can progress to bilateral moyamoya disease with a median probability of 29.01% (ranging from 6.3 to 58.8%), and there are many risk factors that promote its development. Surgical treatment can effectively reduce the incidence of ischemic stroke and improve prognosis. However, the timing and indications for surgery require further investigation. This article reviews the latest research progress on the etiology, epidemiology, clinical and radiological characteristics, progression, treatment, and prognosis of U-MMD.https://www.frontiersin.org/articles/10.3389/fnhum.2025.1503639/fullunilateral moyamoya diseaseetiologyepidemiologyclinical courseprogressionsurgery
spellingShingle Xiaokuan Hao
Cunxin Tan
Ziqi Liu
Yang Tie
Yanru Wang
Shihao He
Ran Duan
Rong Wang
Rong Wang
Research progress in unilateral moyamoya disease
Frontiers in Human Neuroscience
unilateral moyamoya disease
etiology
epidemiology
clinical course
progression
surgery
title Research progress in unilateral moyamoya disease
title_full Research progress in unilateral moyamoya disease
title_fullStr Research progress in unilateral moyamoya disease
title_full_unstemmed Research progress in unilateral moyamoya disease
title_short Research progress in unilateral moyamoya disease
title_sort research progress in unilateral moyamoya disease
topic unilateral moyamoya disease
etiology
epidemiology
clinical course
progression
surgery
url https://www.frontiersin.org/articles/10.3389/fnhum.2025.1503639/full
work_keys_str_mv AT xiaokuanhao researchprogressinunilateralmoyamoyadisease
AT cunxintan researchprogressinunilateralmoyamoyadisease
AT ziqiliu researchprogressinunilateralmoyamoyadisease
AT yangtie researchprogressinunilateralmoyamoyadisease
AT yanruwang researchprogressinunilateralmoyamoyadisease
AT shihaohe researchprogressinunilateralmoyamoyadisease
AT randuan researchprogressinunilateralmoyamoyadisease
AT rongwang researchprogressinunilateralmoyamoyadisease
AT rongwang researchprogressinunilateralmoyamoyadisease